Performance-Based Risk Sharing Agreements for Devices and Diagnostics

Performance-based risk sharing (PBRS) have grown in importance in recent years. While most PBRS are used for expensive pharmaceutical products, PBRS also have been used with medical device and diagnostic manufacturers. Device/diagnostic PBRS may differ from those of pharmaceuticals for a number of reasons. First, while health insurers bear the burden of paying for most pharmaceuticals, device and diagnostics are relatively more likely to be reimbursed by hospitals or health systems.

Read the source article at healthcare-economist.com
2022-01-03 19:41:38